| Followers | 131 |
| Posts | 15004 |
| Boards Moderated | 0 |
| Alias Born | 06/04/2018 |
Friday, June 28, 2019 3:40:28 PM
News: $PTCT PTC Provides Update on Translarna(TM) (ataluren) Application for Label Expansion
SOUTH PLAINFIELD, N.J. , June 28, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has completed their review of a proposed indication extension of Translar...
Read the whole news https://marketwirenews.com/news-releases/ptc-provides-update-on-translarna-tm-ataluren-application-for-l-8429210.html
SOUTH PLAINFIELD, N.J. , June 28, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has completed their review of a proposed indication extension of Translar...
Read the whole news https://marketwirenews.com/news-releases/ptc-provides-update-on-translarna-tm-ataluren-application-for-l-8429210.html
Recent PTCT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 09:20:05 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 05:46:16 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 04:39:10 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/15/2026 02:06:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/14/2026 07:09:46 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/14/2026 04:43:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/12/2026 09:20:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/08/2026 08:15:40 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 08:32:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 08:09:45 PM
- PTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results • PR Newswire (US) • 05/07/2026 08:01:00 PM
- PTC Therapeutics to Participate in Upcoming Investor Conferences • PR Newswire (US) • 05/04/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 08:29:29 PM
- PTC Therapeutics Reports Positive Topline Results from Month 24 Interim Analysis of PIVOT-HD Extension Study of Votoplam • PR Newswire (US) • 04/28/2026 08:05:00 PM
- PTC Therapeutics to Report Results from PIVOT-HD Long Term Extension Study • PR Newswire (US) • 04/28/2026 01:28:00 PM
- PTC Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026 • PR Newswire (US) • 04/22/2026 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/21/2026 08:12:48 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/20/2026 08:31:31 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/20/2026 08:30:30 PM
- PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 04/17/2026 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 09:20:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/06/2026 09:20:08 PM
